MARKET WIREReuters • 3h ago
Iran's IRGC Navy says two tankers 'exploded' after hitting mines in Hormuz - ReutersIran's IRGC Navy says two tankers 'exploded' after hitting mines in Hormuz Reuters
Why NNVC Stock slipped -1.38% Today — RQD Quant Desk Flash
$1.43 -1.38% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $1.42
NanoViricides Inc. (NNVC) carries a Roarable Rating of E (Strong Sell) with 33/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
ROARABLE E • RED ALERT
Cap $36.5M
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $1.42 (-0.44%)🧬 Dilution Drag (+2.48% YoY Shares)⚙️ Cash Engine: 6/20 (E) • 0% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record Warning: Scores below 50 (33/100 · E) historically underperformed SPY in 71% of rolling 90-day windows (-8.9% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →RQD QUANT TACHOMETERRED ALERT • E
3-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw E · Rk D
Each axis scored 0–20
12M PRICE TARGET CONE-11.2% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for NNVC)Realized 20D OHLCV Swing Band: ±12.5%
Deterministic 5-Pillar Attribution (33/100 Composite)
🔍 WHY NNVC SCORES 33/100 (E) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: SEC 10-K Forensic Risk+10/20 pts (30% of score)
Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 2/9
▲ #2 Bullish Driver: Macro Regime Fit+8/20 pts (24% of score)
FRED Regime × Technicals: 42% of 52W Range • RSI-14 at 47 (NEUTRAL RANGE)
▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)
Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade E$1.30+6.2% Next Q
25
Q2 (-2Q)Grade E$1.38+1.4% Next Q
28
Q3 (-1Q)Grade E$1.40+2.1% Next Q
30
CurrentGrade E$1.43-8.9% Hist 90D α
33
Trajectory: E (25) → E (33)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER
⚔️ Adversarial Opposing Case: What Could Spark a NNVC Turnaround Squeeze
While NNVC currently carries a cautious 33/100 (E) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
🚀 Contrarian Squeeze Trigger #1
Established market leader in Health Care with deep daily trading liquidity.
🚀 Contrarian Squeeze Trigger #2
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($1.32) and Max Pain ($1.50) forces dealer call-delta covering toward $2.34.
🚀 Contrarian Squeeze Trigger #3
Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
🎲 LIVE PREDICTION MARKET ODDS TIED TO $NNVC• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “NNVC Beats Next Quarter EPS Consensus (Dec 28, 2026) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why NNVC Stock slipped -1.38% Today — RQD Quant Desk Flash
NanoViricides Inc. (NNVC) slipped -1.38% to $1.43, trading at 42% of its 52-week range ($0.85 – $2.23). Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 42% of its 52-week range ($0.85 – $2.23) with RSI-14 at 47 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±12.5% around $1.43 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable E (Strong Sell) backed by 52% gross margin and $0 annual free cash flow.
Live NNVC Headlines & Catalysts
MARKET WIRECNBC • 5h ago
Here are 3 big things we're watching in the stock market in the week aheadThe market could use a few victories in the days ahead, which will be filled with more earnings, an election, and jobs data.
MARKET WIRECNBC • 5h ago
Democratic Rep. Stevens endorses Rogers over El-Sayed in Michigan Senate electionHaley Stevens had lost the Democratic nomination for Senate in Michigan to Abdul El-Sayed earlier this year.
RISK WATCHReuters • 7h ago
Israeli strikes kill eight people in Gaza - medics say - ReutersIsraeli strikes kill eight people in Gaza - medics say Reuters
MARKET WIREReuters • 8h ago
Russia's FSB says minor detained over park attack threat after US tip-off - ReutersRussia's FSB says minor detained over park attack threat after US tip-off Reuters
MARKET WIREReuters • 9h ago
Iran, Qatari mediators hold third day of talks to end US-Iran war - ReutersIran, Qatari mediators hold third day of talks to end US-Iran war Reuters
CATALYSTReuters • 9h ago
Qatar surges, bucking Gulf market slide on Iran war concerns - ReutersQatar surges, bucking Gulf market slide on Iran war concerns Reuters
MARKET WIREReuters • 10h ago
OPEC+ keeps December oil output targets steady ahead of tougher call for 2027 - ReutersOPEC+ keeps December oil output targets steady ahead of tougher call for 2027 Reuters
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring NNVC)
- ✓Walkthrough of NNVC's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
NNVC // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +15.32%▼ DESCENDING CHANNEL
2026-10-30O $1.41H $1.45L $1.33C $1.43VOL 214.5K
RES: $1.74SUP: $0.89SMA50: $1.32SMA200: $1.29
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
NNVC Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
8.0%/yr Implied 5Y Growth
vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on NNVC today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for NNVC. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for NNVC today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (NNVC)
Health Care Rank #876 of 1016
⚔️ EDSA vs NNVC Full Matrix →
1. Head-to-Head Health Care Peer Comparison (NNVC vs. EDSA, NSRX, LITS, VERU)
Industry: Biotechnology: Pharmaceutical Preparations (489 Tracked Issuers)Across 1016 tracked Health Care securities in the Roarable RQD universe, NanoViricides Inc. (NNVC) ranks #876 by composite RQD confidence (33/100, grade E) and #784 by equity capitalization ($36.5M). Within this direct 5-issuer industry benchmark cohort, NNVC leads on earnings valuation at N/A trailing P/E, while LITS leads on capital efficiency and profitability with -18.9% ROIC and — gross margin. VERU currently holds the highest overall quantitative score in the immediate peer group at 43/100 (D-) compared with NNVC at 33/100 (E).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| NNVC
ACTIVE
NanoViricides Inc. | E | 33/100 | — | — | -35.0% | -1.38% | $36.5M | Benchmark Subject |
| EDSA Edesa Biotech Inc. | D- | 42/100 | — | — | -35.0% | +5.47% | $36.5M | /edsa-vs-nnvc → |
| NSRX Nasus Pharma Ltd. | D- | 36/100 | — | — | -35.0% | -4.49% | $37.4M | /nsrx-vs-nnvc → |
| LITS Lite Strategy Inc. | D- | 42/100 | — | — | -18.9% | -4.88% | $35.6M | /lits-vs-nnvc → |
| VERU Veru Inc. | D- | 43/100 | — | — | -35.0% | -1.76% | $38.0M | /veru-vs-nnvc → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-06-30 • CIK 0001379006In its most recent audited fiscal period (FY2025, filed 2025-06-30), NanoViricides Inc. (NNVC) reported GAAP revenue of $0 (N/A vs. FY2024 revenue of $0 ) , GAAP net income of -$9.5M, operating cash flow of -$8.5M, and free cash flow of -$8.5M (-31.9% YoY). On the balance sheet, NNVC closed FY2025 with $12.3M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 2/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-06-30 | $0 | -$9.5M | -$8.5M | -$8.5M | $12.3M | — |
| FY2024 (FY) | 2024-06-30 | $0 | -$8.3M | -$6.3M | -$6.5M | $11.6M | — |
| FY2023 (FY) | 2023-06-30 | $0 | -$8.6M | -$5.7M | -$5.7M | — | — |
3. NNVC Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs NNVC stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-01, NanoViricides Inc. (NYSE: NNVC) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 33/100 at a spot price of $1.43 (-1.38% 1D, market cap $36.5M). Pillar breakdown: Fundamental Cash Engine 6/20, Institutional 13F & Options Flow 6/20, Executive Insider Alignment 10/20, FRED Macro Regime Fit 8/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, NNVC ranks #876 in composite RQD confidence.
How does NNVC compare to EDSA and NSRX in the Health Care sector?
Within the Health Care sector (Biotechnology: Pharmaceutical Preparations), NNVC carries a Roarable E (33/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of -35.0%. By comparison, EDSA (Edesa Biotech Inc.) holds a D- grade (42/100 RQD, P/E N/A, ROIC -35.0%, cap $36.5M) and NSRX (Nasus Pharma Ltd.) posts a D- grade (36/100 RQD, P/E N/A, ROIC -35.0%, cap $37.4M). Among the 5-stock peer group, NNVC leads on earnings multiple (N/A) while LITS leads on capital efficiency (-18.9% ROIC).
What are the biggest fundamental strengths and SEC risk factors for NNVC?
Per NNVC's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-06-30, CIK 0001379006), NanoViricides Inc. generated $0 in revenue, -$9.5M in net income, and -$8.5M in free cash flow against $12.3M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is NNVC trading relative to its 50-day, 200-day, and 52-week technical levels?
NNVC last traded at $1.43 (-1.38% on volume of 72,812 shares), positioning the stock +8.33% above its 50-day simple moving average ($1.32) and +10.85% above its 200-day simple moving average ($1.29). Across its 52-week range of $0.85 to $2.23, NNVC sits at the 42.0% percentile with a 14-day RSI of 47.0 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($1.25 to $1.61).
NNVC Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is NNVC stock moving today?
Why NNVC Stock slipped -1.38% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.